The Technical Analyst
Vascular Biogenics Ltd [VBLT]
Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Vascular Biogenics Ltd Price, Forecast, Insider, Ratings, Fundamentals & Signals
-8.77% $0.156
America/New_York / 16 okt 2023 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 12.11 mill |
| EPS: | -0.180 |
| P/E: | -0.867 |
| Earnings Date: | Nov 13, 2023 |
| SharesOutstanding: | 77.64 mill |
| Avg Daily Volume: | 0.788 mill |
| RATING 2023-10-16 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Sell | |
| Return On Asset: | Neutral | |
| DE: | Sell | |
| P/E: | Sell | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 1/22 | 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | |
| Revenue | n/a | |||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.867 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.15x |
| Company: PE -0.867 | industry: PE 5.88 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.137 - 0.173 ( +/- 11.61%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-01-02 | Fr Capital Holdings, L.p. | Sell | 50 000 | Ordinary Shares, par value NIS 0.35 each |
| 2023-12-28 | Fr Capital Holdings, L.p. | Sell | 21 500 | Ordinary Shares, par value NIS 0.35 each |
| 2023-12-29 | Fr Capital Holdings, L.p. | Sell | 6 000 | Ordinary Shares, par value NIS 0.35 each |
| 2023-12-26 | Fr Capital Holdings, L.p. | Sell | 11 456 | Ordinary Shares, par value NIS 0.35 each |
| 2023-12-27 | Fr Capital Holdings, L.p. | Sell | 20 033 | Ordinary Shares, par value NIS 0.35 each |
| INSIDER POWER |
|---|
| -42.78 |
| Last 32 transactions |
| Buy: 525 000 | Sell: 1 196 932 |
Forecast:
01:40 - $0.230
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $0.156 (-8.77% ) |
| Volume | 5.38 mill |
| Avg. Vol. | 0.788 mill |
| % of Avg. Vol | 683.03 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For VBLT
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
VBLT
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antibody-based technology that enables specifically inhibit monocyte migration for immune-inflammatory applications. The company's lead product candidate is VB-111, a gene-based biologic that is in Phase III clinical trials for the recurrent platinum-resistant ovarian cancer; and Phase II clinical trials treatment of recurrent glioblastoma and colorectal cancer, as well as has completed Phase II clinical trial for the treatment of thyroid cancer. It is also developing VB-601 for various inflammatory indications, and VB-611 for various solid tumors. The company was formerly known as Medicard Ltd. and changed its name to Vascular Biogenics Ltd. in January 2003. Vascular Biogenics Ltd. was incorporated in 2000 and is headquartered in Modi'in, Israel.
Latest Press Releases
2023-10-16 13:01:00 - Press Release
Notable Labs Closes Merger Transaction With Vbl Therapeutics
- notable expects to initiate trading on the nasdaq capital market under ticker symbol “ntbl” effective at market open on october 17 -
2023-10-12 09:00:00 - Press Release
Vbl Therapeutics Announces Results Of Annual And Special Shareholder Meeting
Approved merger with notable labs and all other proposals merger expected to close and begin trading as combined company under the ntbl ticker on nasdaq next week, subject to effectiveness of approved israeli corporate actions modi'in, israel and new york, oct. 12, 2023 (globe newswire) -- vbl therapeutics (nasdaq: vblt) (“vbl”), today announced that its shareholders voted to approve the previously announced proposed merger (the “merger”) with notable labs, inc. (“notable”), at the annual and special meeting (the “meeting”) which took place today, october 12, 2023. over 98% of the votes cast at the meeting were cast in favor of the approval of the merger.
2023-10-04 08:00:00 - Press Release
Vbl Therapeutics Reminds Shareholders To Vote In The Upcoming Annual And Special Shareholder Meeting
Shareholders of record as of september 5, 2023 are eligible to vote at the vbl shareholder meeting on october 12, 2023 shareholders of record as of september 5, 2023 are eligible to vote at the vbl shareholder meeting on october 12, 2023
2023-09-06 08:00:00 - Press Release
Vbl Therapeutics Announces That S-4 Registration Statement For Proposed Merger With Notable Labs Is Declared Effective By Sec
Merger with notable expected to close in mid-october, subject to shareholder approval special shareholder meeting scheduled for october 12, 2023 modi'in, israel and new york, sept. 06, 2023 (globe newswire) -- vbl therapeutics (nasdaq: vblt) (“vbl”), today announced that its registration statement on form s-4 in connection with the proposed merger with notable labs, inc. (“notable”) has been declared effective by the u.s. securities and exchange commission (“sec”).
2023-08-28 14:48:00 - Press Release
Vascular Biogenics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, Llc Investigates Merger Of Vascular Biogenics Ltd. - Vblt
New orleans--(business wire)--former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed merger of vascular biogenics ltd. operating as vbl therapeutics, (the “company”) (nasdaqgm: vblt) with notable labs, inc. under the terms of the proposed transaction, vascular shareholders will end up owning approximately 24% of the combined company, each on a fully-diluted basis and subject to adjustment. ksf is seek.
Latest News
2023-06-22 10:01:17 - PennyStocks
Best Penny Stocks to Buy Under $1? 10 To Watch Now
Stocks that are priced below $5 per share are typically referred to as penny stocks. However, for the purpose of this article, we will be focusing specifically on penny stocks that are priced under $1.
2023-04-19 15:29:56 - PennyStocks
Penny Stocks To Buy? 10 Under $1 To Watch This Week
2023-04-17 11:15:14 - PennyStocks
Penny Stocks To Buy? 7 Under $1 To Watch This Week
2023-03-03 14:22:29 - PennyStocks
10 Penny Stocks Under $1 To Watch Now, Time To Buy?
Penny stocks under $1 The post 10 Penny Stocks Under $1 To Watch Now, Time To Buy? appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
2023-03-01 14:48:43 - PennyStocks
7 Penny Stocks Under $1 To Watch Now, Time To Buy?
$1 Penny stocks to watch this week. The post 7 Penny Stocks Under $1 To Watch Now, Time To Buy?
2023-03-01 11:52:01 - PennyStocks
Penny Stocks To Buy: 5 To Watch Before Next Week
Penny stocks to watch this week. The post Penny Stocks To Buy: 5 To Watch Before Next Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
2023-02-28 18:40:59 - PennyStocks
4 Penny Stocks Under $1 To Watch Now, Time To Buy?
$1 Penny Stocks To Watch The post 4 Penny Stocks Under $1 To Watch Now, Time To Buy? appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
2023-02-24 06:00:00 - PennyStocks
Maximizing Returns With Penny Stocks: Day Trading
Use these tips to make money with penny stocks when day trading The post Maximizing Returns With Penny Stocks: Day Trading appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
2023-02-23 11:03:13 - InvestorPlace
Why Is Vascular Biogenics (VBLT) Stock Up 52%?
Vascular Biogenics (NASDAQ: VBLT ) stock is rocketing higher on Thursday following news of a merger with Notable Labs. The details of the deal include shareholders of Notable Labs receiving newly-issued shares of VBLT stock.
2023-02-23 10:18:28 - PennyStocks
3 Top Penny Stocks To Watch With Big News Today
Are these penny stocks on your watch list today? The post 3 Top Penny Stocks To Watch With Big News Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.